Otola ryngologists , nu rses, and psychological p rofessionals should be fa miliar with the potential psychiatri c side effec ts of medications that are commo nly prescribed by otolaryngo logists. Because some ofthese side effects are atyp ical, their relati onsh ip to medications might not be obvious. An awareness of the potential fo r psychiat ric side effec ts caused by adrenocort icoids, ant ihistamines and decongestants, and antisecretory medi cat ions will help the clinician avoid or detect and treat drug-ind uced disorders, as will an awa reness of the po tential for side effec ts caused by combinations of medications. Identification of individu al risk fa ctors such as age, pre-existing organic brain disea se, a history ofdru g abu se or dependence, or coex isting orpre-exis ting psychiat ric disorders is important in prevent ing and detectin g drug-induced psychiatric disorders. The drugs discussed in this art icle can have serious, even fatal, intera ctions with certain psychiatric medica tions.
Introduction
Cert ain medi cati on s ro utine ly prescribed by o tolaryngologists can have psychi atri c side effects, including mood disturbances (e.g., agitati o n, anxiety, depre ssion, and mania), perceptual disturbances (e.g., hallu cin atio ns and delusions), cog nitive distu rbances (e.g., delirium and co nfusion ), and behavio ra l disturb ances (e.g., insomnia). Drug-induced psychia tric symptoms ca n occ ur even with standard dosages and at any time durin g the course of treatm ent. Th e combin atio n of some of medications pre sc ribed by otolaryngo logists and psyc hotropic drug s ge nera lly prescribed by psychi atrists has the pote ntial to enha nce or interfere with the therapeutic effects of one or the other. In addit ion to psychi atric side effects, other adverse react ions can occur, such as cardiac arrhyt hmias and hypertension. Certai nly, psychiatric sy mptoms do not alway s reflect a reac tion to a medication , but so me ca n be a manifestation of a coex isting or pre-exist ing psych iatric disord er that has been agg ravated by a co mbination of med ications.
Th e manifestation s of dru g-indu ced psych iatri c disorders ca n be related to dir ect dru g toxicity or to inter ference with the brain ' s metabolism of certain dru gs. The most co mmon psychiatric symptom s includ e de lirium (an acute reacti on with fluctu ati ng aware ness of se lf and environment ), confusion, disori ent ation , trem or, atax ia, and mania. Assoc iated behavioral signs include increased physical act ivity, rapid speec h, inso mnia, and mood eleva tion. Psych iatri c symptoms that occur dur ing the co urse of trea tme nt might also be related to the medical or psychiatric condition being treated. For examp le, anx iety disorders and panic attack s are known to occur in association with thyroid, par athyro id, and adrenoco rtical disor ders; Langhans' ce ll endoc rinop athies; collagen vascular disorders (e.g ., sys te mic lupu s erythematosus, rheumatoid arthritis, temp oral arteritis, and peri arter itis nodosa); and neu rotologic diso rders (e .g., multiple scl eros is and Meniere' s disease). 1Delu sions (the perception that one' s environment and ci rcum stances seem unfam iliar) can occur in assoc iation with certain endocrinopathies. 1 Derealization (the fee ling that familiar eve nts seem unreal, strange, or dream-lik e and that co lors, objects, and shapes appea r to be distorted) as well as delusion s ha ve been rep orted in sys temic lupus erythematos us. 
Psychiatric side effects of specific drugs
Steroids. Adrenocorticoi ds are we ll know n to ca use psychiatric side effects (table) . Deli rium , depression , inso mnia, mani a, and psych oses are not uncommon . Th ese sy mp toms tend to be prop orti on al in inc ide nce to the dosage and dura tion of steroi d use. Iatr ogenic C ushing's syndro me , which ca n be ca use d by lon g-t erm stero id use, can also man ifest and be accompanie d by mood cha nges, depression , eupho ria, or man ia (tablej. ' -'
A person al or famil y hi story of affec tive ment al illn ess ca n pred ispose a patient to the psychi at ric side effec ts of steroids.' Severe depression migh t require antidepressant treatm ent. An antipsy cho tic medi cati on or a mood stabi-qui re as to whe ther a pati ent has experience d an y side effects or abnor mal reac tions fro m an y med ication previous ly taken . 
Antihistamines and decongestants
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Risk factors for drug-induced psychiatric disorders
As always , a detailed history will help the clinician assess eac h pat ient ' s risk. Th e history sho uld include the foll owing six qu estion s:
• What prescription medications and over-the-counter medications is the pati ent currently taking ? • A re there any coex isting medical conditio ns that can cause psychiatri c symptoms? • Is there a personal or fa mily history ofa psychiatric disorder? • If so, did the disorder man if est at an unusual age or in an atypical form ? • Is there a history ofa reaction to a psychiat ric drug ? .
• Is there a history of drug'or alcohol abuse? Th e patient ' s age is also an imp ort ant factor when deciding whic h med ication s to prescribe. Eld erl y patients have a greater risk fo r dru g-indu ced psychiatric disord er s becau se they tend to be takin g more medication s and are therefore mo re likely to exper ien ce dru g interac tions. Old er patient s also tend to have othe r medica l co nditions that can prolon g dru g metab olism and increase sys temic dru g levels.
Pre-exist ing organic bra in disease ca n also be a risk factor for the developme nt of psychi atric side effects, as can dru g abuse. Pati ents who have a history of drug depend en ce or abuse ofte n manifest del irium . Th e presence or history of a mood disorderei ther dep ression or mania-i s also a risk factor for psychiatric side effect s to medic ati on s." Adre nocortico ids ca n agg ravate or unm ask depression or mania in the se pati ent s. Even a famil y history of mani a is a risk fac tor for the development of mania as a side effect.' Assessment of all risk factors is impor tant because multiple facto rs in a parti cul ar pati ent can be additive. Th e ove rall low inci de nce of psychi atri c side effects with a particular medication mig ht inc rease in the presence of other factors. An understanding of the risks in eve ry indi vidu al pati ent is essentia l in sele ct in g me dica tio ns . Ph ys ici an s sho uld routine ly ask pati ent s to brin g in or to make a list of all med ication s they have taken during the previou s 2 mon ths. Clini cian s sho uld also in- 
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For more information Circle 132 on Reader Service Card LEVY, ABAZA , HAW KSHAW , SATALOFF lizer, suc h as divalp roex or lith iu m, might become necessary to treat steroid-induced mani a. In somnia, eit he r as an isol ated side effec t or as part of a manic ep iso de , co uld also req uire med ical int ervent ion.
A ntihistamines anddecongestants. A ntihistami nes and
decongestan ts ca n ca use psychi atric side effec ts ei ther alo ne or in co mbina tio n wit h eac h other (ta ble) ;" T hese medi cation s can be particularly troubl esom e becau se man y antihis tami nes and decon gestant s ca n be purc hased over the co unte r (OT C) and are co nsume d wit ho ut ph ysici an su pe rvision. Moreover, so me pa tients do not eve n realize that their OT C med icati on s inc lude an tihista mine and de congestant compo ne nts. Also , some patien ts do not regard OTC me dications as " rea l medi cines," and so they do not repo rt them as part of thei r medi cal history unl ess they are specifically asked. Medi cati on s th at co ntain phe ny lpropano lamine, pseudoeph edrine, and ph en ylephrine are co ntraind ica ted in pati ent s who are taking a mon oamine ox idase inhibitor (M AOI) ." T hese medicat ion s ca n produce dangerou sly high levels of norepinephrine becau se the MAOI impairs the met abol ism of sy mpa tho mi me tic medi cat ion s.' Sympathom im eti c medi cati on s by themsel ves ca n also ca use psyc hiatr ic side effects. Yo ung children and elde rly pat ie nts with organic brain sy ndrome are the mos t vulnerable. It might become necessary to di scontinue the suspected culpri t med icat ion or to prescribe sed atio n with lorazep am or oxazepa m or treatm ent with a hi gh -p oten cy antipsycho tic suc h as haloperidol. Low-p ot en cy antipsycho tics suc h as thi orid azine or ch lo rpromazine sho uld not be taken with ph en ylp rop anol amine because the co mbin at ion can ca use hyp ot en sion .
Th e antihista mine and an tic ho linergic co mpone nts of a co mb ination antihista mine and decongestant ca n produ ce an atro pine-like psych osis, typ icall y mani festin g as co nfu si on , disori entati on , ag ita tion , hallucin ati on s, and mem or y defi cits. Ag itatio n ca n be treated wi th a sho rtacting, nonantich oliner gic seda tive such as loraze pam or ox aze pa m. Severe agitat ion or psych otic sy m pto ms ca n be treated with low dose s of halop er id ol. Reco very of the pati ent' s ment al status foll ow ing the adm inistration of ph ysostigmin e co nfi rms the di agn osis of atro pi ne-like psychos is." Sy mpto ms sho uld resol ve co mp lete ly after the suspec ted medi cat ion is discon tinued.
Th e hepatic met ab oli sm of man y medi cation s is mediated by ce rtain cy toc hro me P-4S0 enzymes, and the antidepressants fl uvoxamine and nefazodon e interfere wi th ce rtai n P-4S0 enzy mes .7 Wh en these antide pressants are prescr ibed with othe r med icati on s that are metabolized by the sa me P-4S0 enzy mes, co mpe titio n bet ween the me dica tio ns fo r the enzymes impai rs the liver ' s ab ility to met abol ize eac h as effic iently as usu al. Thi s ca n ca use blood level s of these me dicatio ns to becom e dan gerou sly high and lead to sig nifi cant side effec ts or even a fa ta l reactio n."Th ese antide pressants can no t be used in co mbi-nat ion with as te mizole fo r the sa me reason. Loratadine, fe xofen ad ine, and ce tirizi ne can be used with these antidep ressant s becau se they are met abol ized by a differ en t cy toc hro me P-4S0 isozyme.' Reflux medication s. In recent yea rs, otola ryngo logists have begun treatin g more ca ses of laryn gophar yn geal reflux .v? Th e co nditio n is often detected in pati ent s who have voice complai nts . A ntisec re tory medi cati ons, which decr ease sto mac h ac id product ion, are co m mo nly used in the treatm ent of reflux lar yn gitis. Th e two primary classes of drugs prescri bed for th is co nditio n are the prot on pum p in hi bitors and the H 2 receptor antago nists . Th e fo rmer incl udes age nts suc h as o me prazole and lan soprazol e, and the latt er includes dr ugs suc h as fam ot idi ne, nizat id ine, ra ni tidi ne, and cime tidine . All H, antagonis ts have been associated with so me psychi atri c side effec ts (table) . '? Altho ug h the overall incid ence of these side effects in outpatients is less than 0. 2 %, their inci dence is significa ntly higher am on g hospit ali zed patient s, the e lde rly, the serio us ly ill , and those pat ients who have hepat ic or renal fai lure .I I Th e psychiatric side effec ts of the H 2 antagonists vary with res pe ct to their tim e of onse t, but they usu all y resol ve wi thin 3 days of discontinuing the drug . For example, ra nitidine ca n cause depression begi nn in g at 4 to 8 weeks afte r the in itiati on o f trea tme nt. Ci me tid ine has been re po rted to ca use adverse events within 2 to 3 wee ks, and has even ca used delirium wit hin 24 to 48 hours.10 Th e disconti nuatio n of ra nitidine an d ci me tid ine has bee n associated with a wi thdrawal sy ndrome that includes anx iety , insomnia, and irrit ability." Ci meti di ne ca n increase the blood level and ac tion of tr icycl ic antidep res sa nts, suc h as amitripty line , doxep in, imi prami ne, and nortriptylin e; blood level s o f these anti de pressants ca n reach toxic level s, resul ting in tach ycardi a and other side effects.
T he inhibitio n of the cytoc hro me P-4S0 enzymes by ranitid ine or cime tid ine can also lead to pot entiall y dangerous side effects with ce rtai n other psyc hiatri c medi cation s. (C ime tidine is the more potent inhibitor of the two ; ra niti di ne is one-fifth to one-tent h as potent. ) Fa mo tidine and nizatidin e do not inh ib it this enzy me sys te m at all.' ? C ime tidine len gt hens the hal f-life of the antia nxie ty medi cation s clorazep ate, chlordiaze pox ide , and di azep am to a greater degree than does ran itidine." A lower dose of these lon g-acting benzodiazep ines sho uld be co nsi de red whe n they are prescribed for a pa tient who is alrea dy takin g cime tid ine. A n alte rna tive is to use a sho rt-ac ting be nzodiaze pine , suc h as oxazepam or lorazepam . Th e met ab oli sm of these antia nxiety medi cat ion s is not affected by rani tidi ne or cimetidine." As ano the r alternative, a different antire flux medicatio n might be se lec ted.
Ci me tidine ca n also inc rease the blood level s of the serotonin reu ptake inhibitor s, antipsycho tic medi cati on s, in combination with cimet id ine. Th e blood level s of these medications should be monitored peri odi c ally and the ir do sage s adjusted acco rdingly. Another option is to use a different H, antagonist such as fam otidine or nizatidine.
Th e co mb inat ion ofthe proki ne tic medicatio n cisapride and the antide pressa nts fIuv oxamine and nefazodone is of particular co ncern .' Th ese two antide pressa nts slow the metaboli sm o f cisapride and can cause fatal ventricular arrhythm ias. This comb inatio n is listed as a co ntraindication on the drug produ ct information . Another prokineti c medi cation , met oc\ opramide. is mu ch safer to use in combinatio n with these antidepressant s, althoug h it has be en assoc iated with depression and so me neurologic side effects.: s.ro Reach More P ati e nts . 
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